Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Helsinn Healthcare SA
Helsinn Healthcare SA
Eli Lilly and Company
M.D. Anderson Cancer Center
The Hospital for Sick Children
British Columbia Cancer Agency
SWOG Cancer Research Network
University Hospital Freiburg
Duke University
Sichuan Cancer Hospital and Research Institute
Instituto Brasileiro de Controle do Cancer
ChineseAMS
Rafa Laboratories
Consorzio Oncotech
Khon Kaen University
Wake Forest University Health Sciences
Duke University
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
University of Washington
University of Kansas Medical Center
University of Michigan Rogel Cancer Center
Swedish Medical Center
Mashhad University of Medical Sciences
Zhejiang University
University of Rochester
M.D. Anderson Cancer Center
Fraser Health
State University of New York - Upstate Medical University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of South Florida
Bharath Charitable Cancer Hospital and Institute
Fudan University
M.D. Anderson Cancer Center
Ono Pharmaceutical Co. Ltd
Northwestern University
Hallym University Medical Center
GlaxoSmithKline